Gts Securities LLC Cytokinetics Inc Put Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $793,910 - $932,480	15,500 New	15,500 $818,000
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $31.6 Million - $53.6 Million	-495,600 Reduced 73.87%	175,300 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $17.6 Million - $54.7 Million	654,700 Added 4041.36%	670,900 $56 Million
Q3 2023 Nov 15, 2023	BUY	$29.46 - $36.61 $477,252 - $593,082	16,200 New	16,200 $477,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.